SCHEMBL10695564

SCHEMBL10695564

O=[C]CCCN(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 3/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
KCNH2 Q12809 3/20 0.41
SIGMAR1 Q99720 1/20 0.39
KDM4E B2RXH2 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
SMPD1 P17405 1/20 0.35
MEN1 O00255 1/20 0.35
CASP1 P29466 1/20 0.35
BRCA1 P38398 1/20 0.35
CASP7 P55210 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10765887 0.94 MTNR1A (0.41) KCNA3MTNR1AMTNR1BKCNH2SIGMAR1
SCHEMBL10767435 0.87 MTNR1A (0.44) KCNA3MTNR1AMTNR1BKCNH2SIGMAR1
SCHEMBL10697193 0.80 CA12 (0.42) SIGMAR1L3MBTL1MEN1KMT2A
SCHEMBL10695735 0.80 AOC3 (0.36) KCNA3MEN1KMT2ASMN1; SMN2HSD17B10
SCHEMBL4970515 0.79 KCNH2 (0.50) MTNR1AMTNR1BKCNH2SIGMAR1SMPD1
SCHEMBL138431 0.79 KCNH2 (0.50) MTNR1AMTNR1BKCNH2SIGMAR1KDM4E
SCHEMBL154388 0.79 KCNA3 (0.56) KCNA3MTNR1AMTNR1BKCNH2SIGMAR1
SCHEMBL4194250 0.77 KCNH2 (0.48) MTNR1AMTNR1BKCNH2SIGMAR1SMPD1
SCHEMBL10830280 0.77 KCNH2 (0.48) MTNR1AMTNR1BKCNH2SIGMAR1SMPD1
SCHEMBL17743544 0.76 MTNR1A (0.46) KCNA3MTNR1AMTNR1BKCNH2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0252482-A2 7-Acyloxy-6-aminoacyloxypolyoxylabdanes, process for their preparation and their use as medicine HOECHST AKTIENGESELLSCHAFT (DE) 1988-01-13 EP disclosed
EP-0217372-A2 Polyoxygenated labdane derivatives, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-08 EP disclosed